LIVN
LivaNova PLC
NASDAQ: LIVN · HEALTHCARE · MEDICAL DEVICES
$70.09
-1.84% today
Updated 2026-06-05
Market cap
$4.36B
P/E ratio
40.51
P/S ratio
3.04x
EPS (TTM)
$1.96
Dividend yield
—
52W range
$41 – $81
Volume
0.8M
LivaNova PLC (LIVN) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$70.09
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$70.73
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $1.0B | $1.0B | $1.2B | $1.3B | $1.4B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 7.48%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.